Sanofi to Buy Ablynx for $4.85 Billion -- Update

Sanofi SA said Monday it would buy Belgian biotech Ablynx NV for EUR3.9 billion ($4.85 billion), the French drugmaker's second acquisition this month after purchasing U.S. hemophilia specialist Bioverativ Inc. " Sanofi to Buy Ablynx for $4.85 Billion -- Update" via FOX BIZ http://ift.tt/2FpRljp